Comparison of Bivalirudin and Argatroban for the Management of Heparin‐Induced Thrombocytopenia

Abstract

Bivalirudin and argatroban were similar in achieving and maintaining therapeutic anticoagulation goals, clinical outcomes, and safety. This study suggests that bivalirudin represents an alternative in the management of HIT, but prospective studies are needed.